Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Maco Pharma is currently managing 4 pending office actions in the Chemistry & Materials technology area. These actions are distributed across 3 distinct art units, indicating that the company's patent applications cover several different specialized fields. The company is interacting with 4 distinct examiners, meaning that every single pending action is being reviewed by a different official.
The busiest examiner for the company is CHORBAJI, MONZER R, who is responsible for 1 busiest examiner pending action. Because the 4 pending office actions are spread among different examiners, no single official has a dominant influence over the portfolio's current progress. This distribution requires the company to adapt its prosecution strategy to the individual styles of many people. Furthermore, the 3 distinct art units involved mean that the company must navigate the specific procedural nuances of different administrative groups within the Chemistry & Materials sector.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| §103 only | 2 (50%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHORBAJI, MONZER R | 1 | 76.4% | +21.3% |
| KOCH, GEORGE R | 1 | 72.9% | +17.3% |
| BARRON, SEAN C | 1 | 52.9% | +30.9% |
| MENON, KRISHNAN S | 1 | 59.7% | +11.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18843714 | POUCH SYSTEM FOR TREATMENT OF A BIOLOGICAL FLUID BY ELECTROMAGNETIC IRRADIATION | CHORBAJI, MONZER R | — |
| 18268413 | METHOD AND SYSTEM FOR PRODUCING APOPTOTIC MONONUCLEAR CELLS | BARRON, SEAN C | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17758633 | SYSTEM FOR SELECTIVE REMOVAL OF A TARGET SUBSTANCE FROM A BIOLOGICAL FLUID | MENON, KRISHNAN S | 29d |
| 18400773 | Device for Welding a Flexible Medical Tube | KOCH, GEORGE R | 70d |
| 18843714 | POUCH SYSTEM FOR TREATMENT OF A BIOLOGICAL FLUID BY ELECTROMAGNETIC IRRADIATION | CHORBAJI, MONZER R | — |
| 18268413 | METHOD AND SYSTEM FOR PRODUCING APOPTOTIC MONONUCLEAR CELLS | BARRON, SEAN C | — |
| Art Unit | Apps |
|---|---|
| 1745 | 1 |
| 1653 | 1 |
| 1777 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18843714 | POUCH SYSTEM FOR TREATMENT OF A BIOLOGICAL FLUID BY ELECTROMAGNETIC IRRADIATION | CHORBAJI, MONZER R | — | §102§112 | Non-Final OA | — | Pending | Sep 04, 2024 |
| 18400773 | Device for Welding a Flexible Medical Tube | KOCH, GEORGE R | 1745 | §103 | Non-Final OA | 70d | Pending | Dec 29, 2023 |
| 18268413 | METHOD AND SYSTEM FOR PRODUCING APOPTOTIC MONONUCLEAR CELLS | BARRON, SEAN C | 1653 | §101§102§103§112 | Non-Final OA | — | Pending | Dec 08, 2023 |
| 17758633 | SYSTEM FOR SELECTIVE REMOVAL OF A TARGET SUBSTANCE FROM A BIOLOGICAL FLUID | MENON, KRISHNAN S | 1777 | §103 | Final Rejection | 29d | Pending | Jul 12, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial